Premium
Spot urine protein‐to‐creatinine ratio as a diagnostic test in pre‐eclampsia: A gold standard?
Author(s) -
Berthet Angélique,
Bartolo Stéphanie,
Subtil Damien,
Clouqueur Elodie,
Garabedian Charles,
Azaïs Henri
Publication year - 2020
Publication title -
international journal of gynecology and obstetrics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.895
H-Index - 97
eISSN - 1879-3479
pISSN - 0020-7292
DOI - 10.1002/ijgo.13094
Subject(s) - medicine , proteinuria , eclampsia , gold standard (test) , receiver operating characteristic , creatinine , area under the curve , likelihood ratios in diagnostic testing , diagnostic accuracy , prospective cohort study , dipstick , urine , obstetrics , pregnancy , kidney , biology , genetics
Objective To determine the diagnostic accuracy and optimal threshold of the spot protein‐to‐creatinine ratio (PCR) compared to the gold standard, 24‐hour proteinuria (24HP) in patients with suspected pre‐eclampsia. Methods A prospective observational study was performed from June 2015 to May 2017 consisting of patients hospitalized for suspected pre‐eclampsia in a tertiary care referral center. To compare the two diagnostic tests, a spot urine sample was obtained to perform the PCR before starting the collection of the 24HP. Only patients who had both tests were analyzed. Results In total, 148 patients (216 samples) were included. The two tests were highly correlated ( r =0.80, P <0.001). The receiver operating characteristic curve analysis and the area under the curve (AUC=0.92) highlighted the accuracy of PCR in diagnosing significant proteinuria and thus pre‐eclampsia. The optimal cut‐off using the Liu method was 56.9 mg/mmol (sensitivity=79.3%, specificity=91.5%). Conclusion The results suggest that PCR could replace 24HP when diagnosing proteinuria in pre‐eclampsia. Moreover, it is a simple test, easy to realize and standardize, and cheap with no need for systematic hospitalization. The best cut‐off should be chosen by thinking about the risks for adverse maternal and/or fetal outcomes. The test may help to optimize medical care in pre‐eclampsia worldwide.